Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.3 EUR | -4.54% | -5.32% | -16.73% |
Jun. 13 | Formycon Starts Clinical Trials of Keytruda Biosimilar Candidate for Skin Cancer Therapy | MT |
Apr. 25 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
- Stock Market
- Equities
- FYB Stock
- FYB Stock
- News Formycon AG
- Other languages